advertisement
Preliminary statements of the 7th Global WGA Consensus Meeting on Medical Therapy
Fort Lauderdale, FL, USA, May 1, 2010
WHO SHOULD BE TREATED
- Treatment is indicated for patients with glaucoma or glaucoma suspects who are at risk for developing functional impairment or decrease in vision-related quality of life from the disease.
- Treatment decisions should take into account the presence of coexisting ocular conditions, the patient's life expectancy and general health status, as well as his/her perceptions and expectations about treatment.
- Treatment is indicated for patients whose rates of functional or structural progression will most likely result in loss of vision related quality of life over the projected remaining years of life.
- The decision regarding whether or not to treat glaucoma suspects should involve a consideration of risk factors for disease development, including (but not limited to) age, family history of glaucoma, intraocular pressure, central corneal thickness, presence of pseudoexfoliation, disc hemorrhages and measures of structural and functional integrity of the optic nerve head and retinal nerve fiber layer.
- Predictive models or risk calculators may assist clinicians in providing more objective estimates of the risk of glaucoma development for individual patients.
Click here for all Consensus statements and meeting photos
Medical Treatment of GlaucomaWGA consensus series 7
edited by: R.N. Weinreb & J. Liebmann
List price: € 75.00 / US $ 100.00*
ISBN 10: 90-6299-226-9 ISBN 13: 978-90-6299-226-3 (Kugler Publications)
2010. Book. xviii and 309 pages. 9 tables, 4 figures and 57 photos of with 1 in full color. Hardbound.
*IGR Readers: 20% discount on list price. Use discount code IGRC7_2269 when ordering.
Please visit www.kuglerpublications.com for more information
